1. Home
  2. YDES vs DXYZ Comparison

YDES vs DXYZ Comparison

Compare YDES & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$7.43

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Logo Destiny Tech100 Inc.

DXYZ

Destiny Tech100 Inc.

HOLD

Current Price

$28.60

Market Cap

563.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDES
DXYZ
Founded
2013
N/A
Country
Taiwan
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
543.0M
563.5M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
YDES
DXYZ
Price
$7.43
$28.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.2K
2.0M
Earning Date
04-30-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.40
$19.71
52 Week High
$25.00
$50.50

Technical Indicators

Market Signals
Indicator
YDES
DXYZ
Relative Strength Index (RSI) 45.61 53.74
Support Level N/A $28.55
Resistance Level $9.11 $29.14
Average True Range (ATR) 0.87 2.03
MACD 0.18 0.38
Stochastic Oscillator 60.24 47.01

Price Performance

Historical Comparison
YDES
DXYZ

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About DXYZ Destiny Tech100 Inc.

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It is designed to be an investment portfolio of the Top 100 High-Growth Tech Companies.

Share on Social Networks: